Leidos director receives stock and option grants

Leidos Holdings director Gary Stephen May reported equity grants as compensation.

Rhea-AI Filing Summary

Leidos Holdings director Gary Stephen May reported equity grants as compensation. He received 1,067 shares of common stock at no cost, bringing his direct holdings to 11,204 shares. He was also awarded options on 1,281 shares at an exercise price of $131.26 per share.

The stock options vest and become exercisable in full on the earlier of the first anniversary of the grant date or the conclusion of the next annual stockholder meeting, and expire in 2033. These are routine director compensation awards rather than open-market purchases or sales.

Insider Trade Summary

Grant/Award: 2,348 shares

Grant/Award 2 txns

Insider May Gary Stephen

Role Director

Type	Security	Shares	Price	Value
Grant/Award	Stock Option (Right to Buy)	1,281	$0.00	$0.00
Grant/Award	Common Stock	1,067	$0.00	$0.00

Holdings After Transaction: Stock Option (Right to Buy) — 1,281 contracts (Direct); Common Stock — 11,204 shares (Direct)

Footnotes (1)

1. F1. The option shall vest and become exercisable in full on the earlier of (i) the first anniversary of the Grant Date, or (ii) the date that the next annual meeting of the stockholders of the Company is concluded.

Key Figures

Common stock grant: 1,067 shares Shares held after grant: 11,204 shares Option grant size: 1,281 options +3 more

6 metrics

Common stock grant 1,067 shares Director equity award on 2026-05-08

Shares held after grant 11,204 shares Director’s direct holdings following award

Option grant size 1,281 options Right to buy Leidos common stock

Option exercise price $131.26 per share Stock option strike price

Option vesting trigger Earlier of 1 year or next meeting Vesting condition from footnote

Option expiration 2033-05-07 Scheduled option expiry date

Key Terms

stock option, exercise price, vest and become exercisable, annual meeting of the stockholders, +1 more

5 terms

stock option financial

"Stock Option (Right to Buy) with an exercise price of $131.2600"

A stock option is a contract that gives you the right to buy or sell a company's stock at a specific price within a certain time frame. People use them to potentially make money if the stock's price moves favorably or to protect against losses. It's like holding a coupon that can be used to buy or sell stock at a set price later on.

exercise price financial

"conversion_or_exercise_price": "131.2600""

The exercise price is the fixed amount at which you can buy or sell an asset, like a stock, when using an options contract. It matters because it helps determine whether exercising the option will be profitable or not, depending on the current market price. Think of it as the set price you agree on today to buy or sell later.

vest and become exercisable financial

"The option shall vest and become exercisable in full on the earlier of"

annual meeting of the stockholders regulatory

"the date that the next annual meeting of the stockholders of the Company is concluded"

grant, award, or other acquisition financial

"transaction_code_description": "Grant, award, or other acquisition""

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What did Leidos (LDOS) director Gary Stephen May report in this Form 4?

Gary Stephen May reported receiving equity compensation from Leidos. He was granted 1,067 shares of common stock and stock options for 1,281 shares, reflecting routine director awards rather than open-market buying or selling activity in Leidos stock.

How many Leidos (LDOS) shares does Gary Stephen May hold after the reported grants?

After the grant of 1,067 shares, Gary Stephen May directly holds 11,204 shares of Leidos common stock. This increase comes entirely from compensation awards, not from purchasing additional shares in the open market at prevailing trading prices.

What are the key terms of the Leidos (LDOS) stock options granted to Gary Stephen May?

Gary Stephen May received stock options on 1,281 Leidos shares with a $131.26 exercise price. The options vest on the earlier of one year after grant or the next annual stockholder meeting’s conclusion, and they are scheduled to expire in 2033 if not exercised.

Is the Leidos (LDOS) Form 4 for Gary Stephen May a sign of insider buying or selling?

The Form 4 reflects compensation grants, not insider trading. Shares and options were awarded at no cost under a director compensation arrangement, so the filing does not show open-market buying or selling decisions by Gary Stephen May in Leidos stock.

When will Gary Stephen May’s Leidos (LDOS) stock options become exercisable?

The options become exercisable in full on the earlier of two dates: the first anniversary of the grant date or when Leidos’ next annual stockholder meeting concludes. This vesting condition is disclosed directly in the Form 4 footnote language.

AI-generated analysis. How Rhea-AI works. Not financial advice.

Form 4 Insider Transactions: What Each Field Means →

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Accepted by SEC EDGAR 05/12/2026 - 08:55 AM Learn about SEC filing dates

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

May Gary Stephen

(Last) (First) (Middle)

1750 PRESIDENTS STREET

(Street)

RESTON VIRGINIA 20190

(City) (State) (Zip)

UNITED STATES

(Country)

2. Issuer Name and Ticker or Trading Symbol
Leidos Holdings, Inc. [ LDOS ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director		10% Owner
	Officer (give title below)		Other (specify below)

2a. Foreign Trading Symbol

3. Date of Earliest Transaction (Month/Day/Year)
05/08/2026

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock	05/08/2026		A		1,067	A	$0	11,204	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares
Stock Option (Right to Buy)	$131.26	05/08/2026		A		1,281		05/08/2027(1)	05/07/2033	Common Stock	1,281	$0	1,281	D

Explanation of Responses:

1. The option shall vest and become exercisable in full on the earlier of (i) the first anniversary of the Grant Date, or (ii) the date that the next annual meeting of the stockholders of the Company is concluded.

Remarks:

	/s/ Ramune M. Kligys by PoA of Gary Stephen May	05/12/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)